EMEA-000371-PIP01-08 - paediatric investigation plan
lenalidomide
PIPHuman
Celgene Europe Limited
E-mail: medinfo.intl@celgene.com
Country: Switzerland
Phone: +41 327298500
Fax: +41 327298508
P/102/2008: European Medicines Agency decision of 6 November 2008 on the application for product specific waiver for lenalidomide (Revlimid) (EMEA-000371-PIP01-08) in accordance with Regulation (EC) No 1901/2006 of the E...